Help us take a closer look at managing HAE
We are enrolling participants who have been diagnosed with hereditary angioedema (HAE) type I or type II for a clinical research study called the HAE CHAPTER-1 Study. This clinical research study is evaluating an investigational medication called PHVS416: a potential oral treatment option that may prevent HAE attacks.